Purple Biotech (PPBT) Exchange Rate Effect (2017 - 2025)
Purple Biotech (PPBT) reported Exchange Rate Effect of -$1000.0 for Q4 2025, up 93.75% quarter-over-quarter from -$16000.0 in Q3 2025.
Purple Biotech (PPBT) Exchange Rate Effect (2017 - 2025) Analysis & Trends
Purple Biotech (PPBT) has 9 years of Exchange Rate Effect data on file, last reported at -$1000.0 in Q4 2025.
- Exchange Rate Effect for Q4 2025 came in at -$1000.0, changed N/A year-over-year; the trailing twelve-month figure through Dec 2025 was -$14000.0 (down 146.67% YoY), and the FY2025 annual result was $7000.0, up 275.0% from the prior year.
- Exchange Rate Effect advanced to -$1000.0 in Q4 2025 per PPBT's latest filing, from -$16000.0 in the prior quarter.
- Over five years, Exchange Rate Effect peaked at $82000.0 in Q4 2022 and troughed at -$57000.0 in Q3 2022.
- A 5-year average of $2777.8 and a median of -$1000.0 in 2021 frame the typical range for Exchange Rate Effect.
- On a YoY basis, Exchange Rate Effect climbed as much as 783.33% in 2022 and fell as far as 5600.0% in 2022.
- A 5-year view of Exchange Rate Effect shows it stood at -$12000.0 in 2021, then surged by 783.33% to $82000.0 in 2022, then tumbled by 42.68% to $47000.0 in 2023, then sank by 93.62% to $3000.0 in 2024, then plunged by 133.33% to -$1000.0 in 2025.
- Business Quant data shows PPBT's Exchange Rate Effect at -$1000.0 in Q4 2025, -$16000.0 in Q3 2025, and $3000.0 in Q3 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Exchange Rate Effect (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 814,307.08 Bn | 814,307.05 Bn | - | - |
| 2 | Belite Bio | 55,320.00 Bn | 55,320.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,149.72 Bn | 17,149.72 Bn | - | 3.60 Mn |
| 4 | Legend Biotech | 3,590.00 Bn | 3,589.71 Bn | 242.10 Mn | -2.70 Mn |
| 5 | Akari Therapeutics | 1,650.72 Bn | 1,650.72 Bn | - | - |
| 6 | Evaxion A | 1,522.09 Bn | 1,522.07 Bn | - | - |
| 7 | Psyence Biomedical | 229.39 Bn | 229.38 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 113.09 Bn | 105.85 Bn | 2.59 Bn | -40.30 Mn |
| 9 | Abivax | 90.15 Bn | 90.15 Bn | - | 8.68 Mn |
| 10 | Purple Biotech | 242.86 Mn | 236.43 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -1,000.00 |
| Dec 31, 2025 | -1,000.00 |
| Sep 30, 2025 | -16,000.00 |
| Sep 30, 2025 | -16,000.00 |
| Sep 30, 2024 | 3,000.00 |
| Sep 30, 2024 | 3,000.00 |
| Dec 31, 2023 | 47,000.00 |
| Dec 31, 2023 | 47,000.00 |
| Sep 30, 2023 | -20,000.00 |
| Sep 30, 2023 | -20,000.00 |
| Dec 31, 2022 | 82,000.00 |
| Dec 31, 2022 | 82,000.00 |
| Sep 30, 2022 | -57,000.00 |
| Sep 30, 2022 | -57,000.00 |
| Dec 31, 2021 | -12,000.00 |
| Dec 31, 2021 | -12,000.00 |
| Sep 30, 2021 | -1,000.00 |
| Sep 30, 2021 | -1,000.00 |
| Dec 31, 2020 | 75,000.00 |
| Dec 31, 2020 | 75,000.00 |